Pharmacodynamic Comparability

Pharmacodynamic Comparability is the scientific assessment determining whether a generic drug elicits the same qualitative and quantitative pharmacological effects as its reference innovator product, based on the similarity in the time course and magnitude of the biochemical or physiological response following administration at the same dose under similar experimental conditions.

45

Publications

2K

Citations

282

Authors

120

Institutions

Publications per year

2017–2026

4

Publications

45

1–5 of 45

Authors

282

  1. BO
    Bertil Olofsson

    AstraZeneca (Sweden), Sweden

    2 publications · 53 citations

    2

    h-index

  2. AR
    Ann Raes

    Ghent University Hospital, Belgium

    1 publications · 60 citations

    1

    h-index

  3. LK
    LISA K. LAYMAN

    Children’s Minnesota - St. Paul Hospital, United States

    1 publications · 33 citations

    1

    h-index

  4. EK
    Erna Kentala

    Helsinki University Hospital, Finland

    1 publications · 26 citations

    1

    h-index

  5. SJ
    Steven J. Hasal

    University of Arizona, United States

    1 publications · 30 citations

    1

    h-index

1–5 of 282

Venues

  1. British Journal of Clinical Pharmacology

    BJCP · 3 publications · 100 citations

    3

    h-index

  2. Alimentary Pharmacology & Therapeutics

    3 publications · 135 citations

    3

    h-index

  3. Acta Anaesthesiologica Scandinavica

    2 publications · 49 citations

    2

    h-index

  4. Clinical Pharmacology & Therapeutics

    CPT · 2 publications · 194 citations

    2

    h-index

  5. PubMed

    Repository · 2 publications · 42 citations

    2

    h-index

1–5